<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    How did Serina Therapeutics' revenue and expenses shift in Q4 2024?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        5/8/2025 08:44pm
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">Serina Therapeutics reported a total revenue of -$14,000 for Q4 2024, indicating a significant decline from the previous quarter's revenue of $25.6 million. The company's expenses were not provided, so it is difficult to determine the extent of the decline in revenue due to expenses. However, the negative revenue figure suggests that Serina Therapeutics faced considerable challenges in generating income during this period.


|code|Ticker|Name|Date|R&amp;D Expenses|Total Revenue|market_code|
|---|---|---|---|---|---|---|
|SER|SER.A|Serina Therapeutics|2023 Q4|907000|3087000|170|
|SER|SER.A|Serina Therapeutics|2024 Q1|1106000|5000|170|
|SER|SER.A|Serina Therapeutics|2024 Q2|1594000|51000|170|
|SER|SER.A|Serina Therapeutics|2024 Q3|2415000|14000|170|

</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al,am,an,ao,ap,aq,ar,as,at,au,av,aw){return {layout:"default",data:[{noData:c,currentQuestion:g,textDescription:T,comeFrom:"AInvestShareLink",events:[],answerSource:p}],fetch:{},error:q,state:{sharePreviewModule:{loadJgySuccess:e,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:h,agent_id:a,output_media_info:[],task_id:a,language:a,source:p,cache_builder:a,reply_action:"Answer",execute_mode:H,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How did Serina Therapeutics' revenue and expenses shift in Q4 2024?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How did Serina Therapeutics' revenue and expenses shift in Q4 2024?\",\"user_id\":\"dp17002421\",\"user_name\":\"\",\"trace_id\":\"6f1e0c42-a79b-42ce-b406-2a1a7bec2ee1\",\"session_id\":\"6f1e0c42-a79b-42ce-b406-2a1a7bec2ee1\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:"query_data",query_type:j,text:"1 results found:\n|stock code|stock name|Last Price|Last Change|Total Revenue[20241231]|Total Expenses[20241231]|Report End Date|\n|---|---|---|---|---|---|---|\n|SER.A|Serina Therapeutics|$5.75|-0.86%|-$14000||20241231|\n",query_data:{number:h,title:I,query_type:j,condition:a,model_sql:U,data_ext_params:{merge_repeat:c,expand_index:b,data_add:h,add_index:e}}}],answer_chain_name:V,agent_mode:W,native_answer:a,come_from:a,text_answer:T,trace_id:i,cost:18036,event_names:a,question:g,fallback_type:X,input_type:Y,fall_back_reason:{fall_back_type:X,may_fall_back_reason:"UNKNOWN",risk_detail:{matched_words:[]}},session_id:i,first_return_cost:2684,cache_type:"no_cache",question_id:i,transfer_question:g,signal_type:"ON_COMPLETE",start_time:J,remote_svc:p,slots:[],answer_type:H,user_id:z,skill_name:K},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:i,session_id:i,user_id:z,question:g,source:p,raw_question:g,version:"3.4.1",action_name:K,nlu:{entity:[{type:Z,value:r,market:k}]},output_time:J,deep_research:c,deep_thinking:c,agent_mode:W},extra:{}},{answer_path:A,section:{id:B,info_texts:["Thinking"],show_type:C,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"begin"},logs:[],extra:{is_deep_research:c,deep_thinking:c}},{answer_path:A,section:{id:B,info_texts:["Querying Stock: SER Revenue and Expenses in Q4 2024"],show_type:C,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"thinking"},logs:[],extra:{action:"Querying Stock",action_input:I,thought:"The user wants to analyze how Serina Therapeutics' revenue and expenses changed in Q4 2024. I should focus on the company's revenue and expense data for Q4 2024. I will use FinQuery for the data mentioned above."}},{answer_path:d,section:{id:s,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:s,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:A,section:{id:B,info_texts:["Generating Answer"],show_type:C,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"ongoing"},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:t,voice_txt:"Ser",text_answer:_,rich_text:_,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:2000,info_texts:[],show_type:t,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:I,query_type:j,trace_data:a,index:h,model_sql:U,data_ext_params:{merge_repeat:c,expand_index:b,data_add:h,add_index:e},jump_type:"data_query"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:t,voice_txt:". The",text_answer:$,rich_text:$,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:s,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:u,market_id:k,name:n,domain:Z},pos:e,section_id:m,txt:n,jump_type:"pos_fenshi"}],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:s,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:s,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:t,voice_txt:"\n",text_answer:aa,rich_text:aa,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:ab,choice:[],result_page:{components:[{uuid:"b6424075ff636d73",config:{score:116,show_type:ac,scoreRuleNames:"value_unit;data_size;",showDataZoom:b,show_type_id:131,title:"分组柱状图",render:{x:v,y:[D,E]},title_config:{config:{display:b,display2:c,txt_style:e,url:a},data:{h1:ad,h2:a},show_type:L}},data:{chunks_info:"[]",code_count:h,columns:[{index_name:M,key:M,label:"hq_code",source:N,type:f},{domain:F,feKey:O,index_name:O,key:O,label:M,origin_index:"stock code",source:N,type:f,unit:a},{domain:F,feKey:P,index_name:P,key:P,label:"name",origin_index:"stock name",source:N,type:f,unit:a},{feKey:v,index_name:v,key:v,label:"date",origin_index:v,type:"DATE"},{domain:F,feKey:D,index_name:D,key:D,label:a,source:a,timestamp:a,type:ae,unit:af},{domain:F,feKey:E,index_name:E,key:E,label:a,source:a,timestamp:a,type:ae,unit:af},{index_name:ag,key:ag,type:f}],condition:"[{\"sonSize\":4,\"opName\":\"and\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@stock code\",\"indexProperties\":[\"EQUAL SER.A\"],\"indexPropertiesMap\":{\"EQUAL\":\"SER.A\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0},{\"sonSize\":2,\"opName\":\"or\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@R\\u0026D Expenses\",\"indexProperties\":[\"起始交易日期 20231001\",\"截止交易日期 20240930\"],\"indexPropertiesMap\":{\"起始交易日期\":\"20231001\",\"截止交易日期\":\"20240930\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@Total Revenue\",\"indexProperties\":[\"起始交易日期 20231001\",\"截止交易日期 20240930\"],\"indexPropertiesMap\":{\"起始交易日期\":\"20231001\",\"截止交易日期\":\"20240930\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0}]",dataSize:4,datas:[{code:u,"R&D Expenses":907000,"Total Revenue":3087000,Ticker:r,market_code:k,Date:"2023 Q4",Name:n},{code:u,"R&D Expenses":1106000,"Total Revenue":5000,Ticker:r,market_code:k,Date:"2024 Q1",Name:n},{code:u,"R&D Expenses":1594000,"Total Revenue":51000,Ticker:r,market_code:k,Date:"2024 Q2",Name:n},{code:u,"R&D Expenses":2415000,"Total Revenue":14000,Ticker:r,market_code:k,Date:"2024 Q3",Name:n}],meta:{extra:{}},row_count:h,status_code:e,status_msg:"ok"},category:"generic",chart_type:"groupedBar",show_type:ac,title_config:{config:{display:b,display2:c,txt_style:e,url:a},data:{h1:ad,h2:a},show_type:L},support_refresh:b,data_config:{query:a,query_type:j,data_ext_params:{}}}],global:{query_type:j},page:{language:a,layout:{layout_data:"[{\"children\":[],\"showType\":\"bar3\",\"uuid\":\"b6424075ff636d73\"}]"},render_for:Q},data_config:{query:a,query_type:j,data_ext_params:{}}},tag_info_list:[],is_last:c,uuid:"4deb36e7-9025-4f29-9957-5b594ded91e2"},logs:[],extra:{}},{answer_path:d,section:{id:m,info_texts:[],show_type:t,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:A,section:{id:B,info_texts:["Completed"],show_type:C,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:ab,choice:[{display_text:w,query_text:w,trace_info:{item_id:"8394e29290b81915ea2aeb93a434e900",item_type:o,item_name:w,rec_info:ah}},{display_text:x,query_text:x,trace_info:{item_id:"7b7d948ef02e18a18d3699b95c6173a4",item_type:o,item_name:x,rec_info:ai}},{display_text:y,query_text:y,trace_info:{item_id:"335d4d63d99193aec4b5f7925a636b75",item_type:o,item_name:y,rec_info:aj}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:L,data:{h1:a,h2:a},config:{display:c,txt_style:e,type:"1",display2:c,url:a}},request_config:[{source_type:ak,related_name:al}],puuid:R,tag:a,category:"custom",uuid:am}],global:{urp_static_data:[{name:al,value:{status_code:e,columns:[{type:f,index_name:an,key:an},{type:f,index_name:ao,key:ao},{type:f,index_name:ap,key:ap},{type:f,index_name:aq,key:aq},{type:f,index_name:ar,key:ar}],datas:[{send_text:w,item_type:o,rec_info:ah,display_text:w,rec_reason:a},{send_text:x,item_type:o,rec_info:ai,display_text:x,rec_reason:a},{send_text:y,item_type:o,rec_info:aj,display_text:y,rec_reason:a}],dataSize:ak,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:9999,label:as,type:"thslc\u002Fthslc-common-container",leaf:c,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:b,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:G,"min-height":"100%",position:at,height:G},isMaterial:c,id:as,needTheme:c,hasEditor:c,packed:c,events:[],child:[{readmeUrl:"https:",stack:c,visible:b,customStyle:a,childLimit:e,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:b,version:"1.12.0",animate:[],url:S,componentUuid:am,script:[{name:au,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:b,renderType:"blue"},path:S,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:S},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:G,position:at,height:G},isMaterial:b,_id:19,id:au,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:Q,voice_txt:a,tracking_info:{},uuid:R},order:{is_auto:c,render_for:Q,chart_type:"command",puuid:R}},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1003,info_texts:[],show_type:l,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{action_name:K,with_paid_index:c,no_refresh_answer:c,answer_source:{agent_id:a,agent_name:a,execute_mode:H,answer_chain_name:V},is_deep_research:c,deep_thinking:c,create_time:1746708310288},is_last:b}],questionItem:{data:{qStr:g,encodeFlag:c,imageData:q,docsData:[],quoteData:q},tplType:"question"},events:av,agentId:a,param:{entity_info:{},add_info:{ori_question:g},event_list:av,client_ip:a,question:g,user_id:z,user_name:a,trace_id:i,session_id:i,source:p,input_type:Y}}],userId:z,userName:a,startTime:J,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:q,endSignal:c,theme:"white",showTracePopup:c,traceListData:[],chatTraceTargetIndex:e,traceTableData:q,showMask:c}},serverRendered:b,routePath:"\u002Faime\u002Fshare\u002Fhow-did-serina-therapeutics-revenue-and-expenses-shift-in-q4-2024-784ef6\u002F",config:{_app:{basePath:aw,assetsPath:aw,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",true,false,"other\u002FopenAnswer",0,"STR","How did Serina Therapeutics' revenue and expenses shift in Q4 2024?",1,"6f1e0c42-a79b-42ce-b406-2a1a7bec2ee1","intusstock","170","signal",2001,"Serina Therapeutics","llm_generated","ths_ainvest_lite_web",null,"SER.A",999,"rich_text","SER","Date","What are the analysts' expectations for Serina Therapeutics' future revenue and expense trends?","What were Serina Therapeutics' revenue figures for Q4 2024?","How did Serina Therapeutics' net income or loss change in Q4 2024?","dp17002421","progress\u002Fsearching_for",1000,"searching_for","R&D Expenses","Total Revenue","abs_国际美股领域","auto","agent","SER Revenue and Expenses in Q4 2024",1746708292252,"inspect stocks","title1","code","fixed_index","Ticker","Name","aigc","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Serina Therapeutics reported a total revenue of -$14,000 for Q4 2024, indicating a significant decline from the previous quarter's revenue of $25.6 million. The company's expenses were not provided, so it is difficult to determine the extent of the decline in revenue due to expenses. However, the negative revenue figure suggests that Serina Therapeutics faced considerable challenges in generating income during this period.\n\n\n|code|Ticker|Name|Date|R&D Expenses|Total Revenue|market_code|\n|---|---|---|---|---|---|---|\n|SER|SER.A|Serina Therapeutics|2023 Q4|907000|3087000|170|\n|SER|SER.A|Serina Therapeutics|2024 Q1|1106000|5000|170|\n|SER|SER.A|Serina Therapeutics|2024 Q2|1594000|51000|170|\n|SER|SER.A|Serina Therapeutics|2024 Q3|2415000|14000|170|\n\n","select   stock_code,   total_revenue,   total_expenses from   ustock_fin_data where   report_end_date = date('2024y4q')   and stock_code = 'SER.A'","agent_common_v2\nagent-summary","normal_agent","NONE","typewrite","stock","Serina Therapeutics reported a total revenue of -$14,000 for Q4 2024, indicating a significant decline from the previous quarter's revenue of $25.6 million[^1]",". The company's expenses were not provided, so it is difficult to determine the extent of the decline in revenue due to expenses. However, the negative revenue figure suggests that Serina Therapeutics faced considerable challenges in generating income during this period.\n\n","\n``` visual\n{\"uuid\":\"4deb36e7-9025-4f29-9957-5b594ded91e2\"}\n```","result_page","bar3","SER R&D Expenses, Total Revenue","DOUBLE","USD","market_code","2+679_496_21_554+0+0+6f1e0c42-a79b-42ce-b406-2a1a7bec2ee1+8394e29290b81915ea2aeb93a434e900+llm_generated+aimeTagAnalysis+0+0.007358480244874954+1","2+679_496_21_554+0+0+6f1e0c42-a79b-42ce-b406-2a1a7bec2ee1+7b7d948ef02e18a18d3699b95c6173a4+llm_generated+aimeTagAnalysis+0+0.004268280696123838+2","2+679_496_21_554+0+0+6f1e0c42-a79b-42ce-b406-2a1a7bec2ee1+335d4d63d99193aec4b5f7925a636b75+llm_generated+aimeTagAnalysis+0+0.003092688275501132+3",3,"recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>